Mark Lappe - 03 Jan 2023 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Chief Executive Officer, Director
Signature
/s/ Kelly D. Deck, attorney-in-fact
Issuer symbol
INBX
Transactions as of
03 Jan 2023
Transactions value $
$0
Form type
4
Filing time
03 Jan 2023, 17:11:52 UTC
Previous filing
20 Dec 2022
Next filing
24 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +100,000 $0 100,000 03 Jan 2023 Common Stock 100,000 $23.3 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments forthirty-six (36) months thereafter.